- Net revenue of $460 million, a 4.8% increase over prior year - Earnings per diluted share of $0.29 excluding special items, a 21% increase over prior year
- Earnings per diluted share of $0.16 including special items - Closed on the Baptista's acquisition and finalized efforts to sell Private Brands - Initiated Margin Improvement & Restructuring Plan CHARLOTTE, N.C. , Aug.
Solazyme, Inc. (NASDAQ:SZYM), a renewable oil and bioproducts company,
today announced its participation in the Jefferies 2014 Global
Industrials Conference and the Pacific Crest 16 th Annual
Global Technology Leadership Forum.
Networks , Inc. (Nasdaq: SONS), a global
leader in securing real-time communications , today announced that
the Sonus SBC SWe (Software edition) has achieved Microsoft Lync 2013
qualification for Session Border Controller (SBC) deployments.
Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a
biopharmaceutical company developing PRX302 for the treatment of the
symptoms of benign prostatic hyperplasia (BPH, enlarged prostate) and
for the treatment of localized prostate cancer, today announced
financial results and recent key operational and financial highlights
for the three and six months ended June 30, 2014.
LAS VEGAS , July 31, 2014 /PRNewswire/ -- Senior management of Southwest Gas Corporation (NYSE: SWX) is holding a conference call to discuss the Southwest 2014 second quarter and twelve-months results on Thursday, August 7, 2014 .
Sparton Corporation (NYSE:SPA) announced today that Cary Wood,
Chief Executive Officer, will be presenting at the Jefferies 2014 Global
Industrials Conference to be held at the Grand Hyatt Hotel in New York.
The Financial Select Sector SPDR® Fund (NYSE: XLF -
announced today that the Fund received payment as an authorized claimant
from a class action settlement related to Citigroup, Inc.
The total amount payable to the Fund is listed below.
Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company
with fully integrated commercial and drug development operations with a
primary focus in hematology and oncology, announced today financial
results for the three-month period ended June 30, 2014.
Springleaf Holdings, Inc. (NYSE:LEAF), today reported net income of $72
million, or $0.63 per diluted share for the second quarter of 2014,
compared with net income of $56 million or $0.56 per diluted share in
the second quarter of 2013 (based on the pre-initial public offering
share count of 100 million shares).
Net income in the second quarter of 2014 included a $35 million pretax
net gain from the sale of approximately $500 million of real estate
assets in June 2014 1,2 , and net income in the prior year
quarter included a $41 million pretax gain from the sale of previously
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.